首页|血清MMP-2、OPN对终末期肾病血液透析患者血管钙化的诊断价值

血清MMP-2、OPN对终末期肾病血液透析患者血管钙化的诊断价值

扫码查看
目的:探讨终末期肾病血液透析患者血清基质金属蛋白酶-2(MMP-2)、骨桥蛋白(OPN)对血管钙化的诊断价值。方法:选取 2021 年 6 月—2022 年 12 月首都医科大学石景山教学医院肾内科收治 135 例的终末期肾病患者为研究对象,采用影像学检测方法评估患者血管钙化情况,并分为钙化组(59 例)与非钙化组(76 例),比较钙化组和未钙化组基线资料和实验室指标,分析终末期肾病血液透析患者发生血管钙化的危险因素,分析MMP-2、OPN诊断终末期肾病血液透析患者血管钙化的价值。结果:135 例终末期肾病血液透析患者发生血管钙化 59 例,占 43。70%。两组血肌酐、血钙、血磷、血清MMP-2、OPN比较,差异有统计学意义(P<0。05)。logistic回归分析结果显示,血肌酐、血钙、血磷、MMP-2、OPN高水平与终末期肾病血液透析患者血管钙化的危险因素(OR>1,P<0。05)。绘制受试者工作特征(ROC)曲线,结果显示,血清MMP-2、OPN诊断终末期肾病患者血管钙化的曲线下面积(AUC)均>0。7,具有一定诊断价值,其中联合检测诊断价值最高。结论:血清MMP-2、OPN在终末期肾病血液透析患者呈高表达,且其在诊断血管钙化中具有良好的应用价值。
Diagnostic Value of Serum MMP-2 and OPN for Vascular Calcification in Hemodialysis Patients with End-stage Renal Disease
Objective:To investigate the diagnostic value of serum matrix metalloproteinase-2(MMP-2)and osteopontin(OPN)in vascular calcification in patients with end-stage renal disease on hemodialysis.Method:A total of 135 patients with end-stage renal disease admitted to the Nephrology Department of Shijingshan Teaching Hospital,Capital Medical University from June 2021 to December 2022 were selected as the study objects.Imaging methods were used to evaluate the vascular calcification of the patients,and the patients were divided into calcified group(59 cases)and non-calcified group(76 cases).Baseline data and laboratory indicators of the calcified group and the non-calcified group were compared.The risk factors of vascular calcification in patients with end-stage renal disease on hemodialysis were analyzed,and the value of MMP-2 and OPN in diagnosing vascular calcification in patients with end-stage renal disease on hemodialysis were analyzed.Result:Vascular calcification occurred in 59(43.70%)of 135 patients with end-stage renal disease on hemodialysis.There were significant differences in serum creatinine,serum calcium,serum phosphorus,serum MMP-2 and OPN between the two groups(P<0.05).logistic regression analysis showed that high levels of serum creatinine,serum calcium,serum phosphorus,MMP-2 and OPN were risk factors for vascular calcification in patients with end-stage renal disease on hemodialysis(OR>1,P<0.05).Receiver operating characteristic(ROC)curve was drawn,and the results showed that the area under cruve(AUC)of serum MMP-2 and OPN in the diagnosis of vascular calcification in patients with end-stage renal disease was>0.7,which had certain diagnostic value,and the combined detection had the highest diagnostic value.Conclusion:Serum MMP-2 and OPN are highly expressed in hemodialysis patients with end-stage renal disease,and they have good application value in diagnosing vascular calcification.

End-stage renal diseaseHemodialysisMatrix metalloproteinase-2OsteopontinVascular calcification

郭燕

展开 >

首都医科大学石景山教学医院(北京市石景山医院) 北京 100043

终末期肾病 血液透析 基质金属蛋白酶-2 骨桥蛋白 血管钙化

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(6)
  • 24